Dr. O'Reilly on Areas of Research in Pancreatic Cancer

Video

Eileen O’Reilly, MD, associate director for clinical research at Memorial Sloan Kettering Cancer Center discusses areas of research for patients with pancreatic cancer.

Eileen O’Reilly, MD, associate director for clinical research at Memorial Sloan Kettering Cancer Center discusses areas of research for patients with pancreatic cancer.

The focus of research in pancreatic cancer has mainly been in the metastatic setting, explains O’Reilly. There will be a rise in the incidence of pancreatic cancer making early detection an important area of study. There have been some early hints of the ability to identify who might be at risk.

For example, in certain families where there is a genetic driver of the disease, such as a BRCA mutation or Lynch syndrome, some physicians may recommend family members get screened as they may be carriers.

Bringing drugs that had traditionally been developed for patients with early-stage disease to patients whose tumors were resected could help increase the cure rate, says O’Reilly.

Related Videos
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,